<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02465307</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201400546 -N</org_study_id>
    <secondary_id>1750192</secondary_id>
    <secondary_id>1R21EB027344-01</secondary_id>
    <secondary_id>R01NS120924-01</secondary_id>
    <nct_id>NCT02465307</nct_id>
  </id_info>
  <brief_title>Intelligent Intensive Care Unit</brief_title>
  <acronym>ICU_Delirium</acronym>
  <official_title>Motion Analysis of Delirium in Intensive Care Units (ICUs) Subtitle 1: &quot;ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>U.S. National Science Foundation</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute for Biomedical Imaging and Bioengineering (NIBIB)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Delirium, as a common complication of hospitalization, poses significant health problems in&#xD;
      hospitalized patients. Though about a third of delirium cases can benefit from intervention,&#xD;
      detecting and predicting delirium is still very limited in practice. A common&#xD;
      characterization of delirium is change in activity level, causing patients to become&#xD;
      hyperactive or hypoactive which is manifested in facial expressions and total body movements.&#xD;
      This pilot study is designed to test the feasibility of a delirium detection system using&#xD;
      movement data obtained from 3-axis wearable accelerometers and commercially available camera&#xD;
      with facial recognition video system in conjunction with electronics medical record (EMR)&#xD;
      data to analyze the relation of whole-body movement and facial expressions with delirium.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to assess the potential of using motion and facial expression data to&#xD;
      detect delirium in ICU patients by comparing motion and facial expression patterns in&#xD;
      delirium and control groups. In this study, the investigators will use ActiGraph&#xD;
      accelerometers to record each subject's movement patterns. Also, a processed video using a&#xD;
      commercially available camera interfaces with a specialized program to identify patient&#xD;
      facial expressions and movement patterns. A total of 60 participants will be enrolled with&#xD;
      delirium, and 30 patients without delirium will be used as control group. Motion profiles&#xD;
      will be compared in the motorically defined subgroups (hyperactive, hypoactive, normal) based&#xD;
      on accelerometer and facial recognition data. Then, differences in facial expression, number&#xD;
      of changes in postures, and percentage of time spent moving will be compared between&#xD;
      motorically defined subgroups and in delirium and control groups. EMR data will also be used&#xD;
      to assess the feasibility of detecting delirium by including additional information on&#xD;
      related risk factors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>CAM/CAM-ICU</measure>
    <time_frame>Changes from Baseline up to 7 Days</time_frame>
    <description>Confusion Assessment Method for detection of delirium</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Memorial Delirium Assessment Scale (MDAS) will be used for changes from baseline up to 7 days between the groups.</measure>
    <time_frame>Changes from Baseline up to 7 Days</time_frame>
    <description>MDAS denotes motor profile and defines motor subtyping. It has 10 items which assesses several areas of cognitive functioning (memory, attention, orientation and disturbances in thinking) and psychomotor activity. The items are rated on a four point scale (0-3) based on the current interaction with the patient or by assessment of behavior. A score of 13 shows the diagnosis of delirium.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Delirium Motor Subtyping Scale (DMSS-4) will be used for changes from baseline up to 7 days between the groups.</measure>
    <time_frame>Changes from Baseline up to 7 Days</time_frame>
    <description>Scoring from DMSS-4 which has 5 hyperactive and 8 hypoactive symptoms requires at least two symptoms to be present from either the hyperactive or hypoactive list to meet subtype criteria. The higher the score the higher the delirium.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Freedman Sleep Scale</measure>
    <time_frame>Changes from Baseline up to 7 Days</time_frame>
    <description>To determine sleep quality of patient for given day.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of subjects who died</measure>
    <time_frame>Baseline up to 7 Days</time_frame>
    <description>Death at any time during admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of subjects on mechanical ventilation</measure>
    <time_frame>greater than 48 hours</time_frame>
    <description>Number of subjects requiring mechanical ventilation greater than 48 hours.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Facial amimia versus non-amimia expressions between the groups</measure>
    <time_frame>Changes from Baseline up to 7 Days</time_frame>
    <description>Frequency of presence of facial amimia versus non-amimia expressions between the groups.</description>
  </other_outcome>
  <other_outcome>
    <measure>Dynamic activity versus static position</measure>
    <time_frame>Changes from Baseline up to 7 Days</time_frame>
    <description>Percentage of time spent moving versus static position</description>
  </other_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Delirium</condition>
  <condition>Confusion</condition>
  <arm_group>
    <arm_group_label>Delirium group</arm_group_label>
    <description>ICU patients with a positive Confusion Assessment Method (CAM) score; observational using accelerometers, commercially available camera, and Internet Pod (iPod).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>ICU patients with a negative Confusion Assessment Method (CAM) score; observational using accelerometers, commercially available camera, and Internet Pod (iPod).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy control group</arm_group_label>
    <description>Healthy subjects that sleep in their home environment; observational using accelerometers, cortisol swabs, and Internet Pod (iPod)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Confusion Assessment Method</intervention_name>
    <description>Confusion Assessment Method (CAM) score</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Delirium group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Accelerometer</intervention_name>
    <description>3 accelerometers (placed on upper arm, wrist and ankle) and 1 placed on wall as ambient light sensor</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Delirium group</arm_group_label>
    <arm_group_label>Healthy control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Commercially available camera</intervention_name>
    <description>As part of facial recognition video system</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Delirium group</arm_group_label>
    <other_name>imaging</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Internet Pod (iPod)</intervention_name>
    <description>Monitors noise levels in the room</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Delirium group</arm_group_label>
    <arm_group_label>Healthy control group</arm_group_label>
    <other_name>Sound detection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cortisol Swab</intervention_name>
    <description>Cortisol level collected through self administered salivary swab</description>
    <arm_group_label>Healthy control group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        ICU Patients: Patients who been hospitalized in an intensive care unit and have risk&#xD;
        factors to develop delirium or delirium has been suspected by their medical provider.&#xD;
&#xD;
        Healthy Controls: People who are healthy and sleep in their home environment.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria (ICU Patients):&#xD;
&#xD;
          -  Intensive care unit patient&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
        Exclusion Criteria (ICU Patients):&#xD;
&#xD;
          -  Anticipated intensive care unit stay less than one day&#xD;
&#xD;
          -  Less than 18 years of age&#xD;
&#xD;
          -  Inability to wear a motion sensor watch (ActiGraph)&#xD;
&#xD;
        Inclusion Criteria (Healthy Controls):&#xD;
&#xD;
          -  18 years of age or older.&#xD;
&#xD;
          -  sleeps in home environment&#xD;
&#xD;
        Exclusion Criteria (Healthy Controls):&#xD;
&#xD;
          -  does not sleep in home environment&#xD;
&#xD;
          -  Less than 18 years of age&#xD;
&#xD;
          -  Inability to wear a motion sensor watch (ActiGraph)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Azra Bihorac, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julie S Cupka, BS</last_name>
    <phone>352-294-8776</phone>
    <email>jcupka@ufl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haleh Hashemighouchani, MD</last_name>
    <phone>352-294-8776</phone>
    <email>Haleh.Hashemighouchani@medicine.ufl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UF Health</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie S Cupka, BS</last_name>
      <phone>352-294-8776</phone>
      <email>jcupka@ufl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Azra Bihorac, MD</last_name>
      <phone>352-273-8821</phone>
      <email>Azra.Bihorac@medicine.ufl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Parisa Rashidi, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>May 29, 2015</study_first_submitted>
  <study_first_submitted_qc>June 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2015</study_first_posted>
  <last_update_submitted>March 22, 2021</last_update_submitted>
  <last_update_submitted_qc>March 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Consciousness</keyword>
  <keyword>Alertness</keyword>
  <keyword>Cognition</keyword>
  <keyword>Activity level</keyword>
  <keyword>Delirium</keyword>
  <keyword>Hyperactive delirium</keyword>
  <keyword>Hypoactive delirium</keyword>
  <keyword>Facial expression</keyword>
  <keyword>Posture</keyword>
  <keyword>Intensive care unit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Confusion</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

